NCT06237257 2024-12-24
A Study of Chemoradiotherapy With SHR-1316 For Treatment of Locally Advanced Cervical Cancer
Shanghai Shengdi Pharmaceutical Co., Ltd
Phase 2 Active not recruiting
Shanghai Shengdi Pharmaceutical Co., Ltd
AstraZeneca
Fondazione Policlinico Universitario Agostino Gemelli IRCCS